Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNinety One Regulatory News (N91)

Share Price Information for Ninety One (N91)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 175.40
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.40 (0.228%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 175.40
N91 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

3 Nov 2023 07:05

RNS Number : 2433S
Ninety One PLC
03 November 2023
 

Ninety One plc ? ? Ninety One Limited

Incorporated in England and Wales ? Incorporated in the Republic of South Africa

Registration number 12245293 ? Registration number 2019/526481/06

Date of registration: 4 October 2019 ? Date of registration: 18 October 2019

LSE share code: N91 ? JSE share code: NY1

JSE share code: N91 ? ? ISIN: ZAE000282356

ISIN: GB00BJHPLV88

 

As part of the dual-listed company structure, the boards of Ninety One plc and Ninety One Limited (together the 'Board') notify both the London Stock Exchange and the JSE Limited ('JSE') of matters which are required to be disclosed under the FCA Disclosure Guidance and Transparency Rules and Listing Rules of the United Kingdom Listing Authority (the 'UKLA') and/or the JSE Listings Requirements (the 'Listing Requirements').

 

Ninety One Limited Ordinary Share Buyback

Ninety One Limited (the 'Company') advises that, at the close of business on 01 November 2023, it has cumulatively repurchased 8,900,922 of the Company's ordinary shares ('Ordinary Shares') representing 3.007% of the issued Ordinary Share capital as at the date of the general authority granted by shareholders at the Company's annual general meeting held on 26 July 2023 ('General Authority').

The Ordinary Shares were repurchased for an aggregate value of R345,632,678.38. Details of the repurchase are set out in the table hereunder:

 

Repurchase period

Number and percentage of shares repurchased

Highest repurchase price per share (R)

Lowest repurchase price per share (R)

Aggregate value (R)

Number and percentage of shares outstanding in relation to the total shares under the General Authority

27 July -

1 November 2023

8,900,922

3.007%

R40.00

R35.89

R345,632,678.38

20,695,450

6.993%

 

An application will be made to the JSE to de-list 307,360 Ordinary Shares, at which point they will be immediately cancelled. 8,593,562 Ordinary Shares have already been cancelled. The Ordinary Shares remaining in issue following the cancellation of the aforementioned shares amounts to 287,062,798. The Company does not hold any treasury shares.

 

The impact of the repurchase of the Ordinary Shares on the financial information of the Company is immaterial. The Ordinary Shares were repurchased from excess cash resources of the Company; going forward, no Ordinary Share dividends will be payable on the repurchased Ordinary Shares and interest earned on the cash utilised for the repurchases will be foregone. 

 

On 27 July 2023, in accordance with paragraph 5.72(h) of the JSE Listings Requirements, the Company entered into a mandate (the 'Mandate') with an independent agent to undertake its repurchase programme. Under the Mandate, the repurchase programme continued during the Company's closed period from 1 October to 15 November 2023. The repurchases were made in terms of the current General Authority effected through an order book operated by the JSE and executed without any prior understanding or arrangement between the Company and the counterparties. Accordingly, the Company has complied with paragraph 5.72(a) of the Listings Requirements.

 

 

Statement by the Board

The Board has considered the effect of the repurchases and is of the opinion that, for a period of 12 months following the repurchases, the:

? Company and its subsidiaries (the 'Group') will be able, in the ordinary course of business, to pay its debts;

? consolidated assets of the Company and the Group will be in excess of the consolidated liabilities;

? share capital and reserves of the Company and the Group will be adequate for ordinary business purposes; and

? working capital of the Company and the Group will be adequate for ordinary business purposes.

 

 

For enquiries please contact:

 

Investor relations

Alvar Fernandez alvar.fernandez@ninetyone.com +44 (0) 20 3938 2305

Jakub Vojtek jakub.vojtek@ninetyone.com +44 (0) 20 3938 2413

 

 

Date of release: ?03 November 2023

JSE Sponsor: J.P. Morgan Equities South Africa (Pty) Ltd

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEAKFAEEEDFFA
Date   Source Headline
17th Aug 20234:00 pmRNSDirector/PDMR Shareholding
17th Aug 20232:00 pmRNSDirector/PDMR Shareholding
16th Aug 20232:00 pmRNSDealing In Securities by Employee Benefit Trusts
10th Aug 20234:00 pmRNSHolding(s) in Company
10th Aug 202312:00 pmRNSDirector/PDMR Shareholding
8th Aug 20234:00 pmRNSDirector/PDMR Shareholding
7th Aug 20231:00 pmRNSDirector/PDMR Shareholding
3rd Aug 20232:00 pmRNSDirector/PDMR Shareholding
3rd Aug 20232:00 pmRNSHolding(s) in Company
27th Jul 20231:00 pmRNSDirector/PDMR Shareholding
26th Jul 20234:30 pmRNSHolding(s) in Company
26th Jul 20234:30 pmRNSResult of AGM
17th Jul 202310:00 amRNSHolding(s) in Company
14th Jul 20237:00 amRNS1st Quarter Update
13th Jul 20231:00 pmRNSDirector/PDMR Shareholding
10th Jul 20232:00 pmRNSB-BBEE Act: Annual Compliance Report
10th Jul 20231:00 pmRNSDirector/PDMR Shareholding
29th Jun 20231:00 pmRNSDirector/PDMR Shareholding
28th Jun 20232:00 pmRNSDirector/PDMR Shareholding
23rd Jun 202312:00 pmRNSDealing In Securities by Employee Benefit Trusts
21st Jun 20231:00 pmRNSDealing In Securities by Employee Benefit Trusts
20th Jun 20232:00 pmRNSDealing In Securities by Employee Benefit Trusts
19th Jun 20232:00 pmRNSDealing In Securities by Employee Benefit Trusts
15th Jun 20232:00 pmRNSDealing In Securities by Employee Benefit Trusts
14th Jun 20233:30 pmRNSDealing In Securities by Employee Benefit Trusts
14th Jun 20233:30 pmRNSAnnual Financial Report and Notice of AGM
13th Jun 20233:30 pmRNSDealing In Securities by Employee Benefit Trusts
12th Jun 20232:00 pmRNSDealing In Securities by Employee Benefit Trusts
9th Jun 20234:00 pmRNSDealing In Securities by Employee Benefit Trusts
6th Jun 20233:00 pmRNSDirector/PDMR Shareholding
6th Jun 20233:00 pmRNSDealing In Securities by Employee Benefit Trusts
5th Jun 20233:00 pmRNSDealing In Securities by Employee Benefit Trusts
2nd Jun 20232:00 pmRNSDealing In Securities by Employee Benefit Trusts
1st Jun 20234:00 pmRNSDealing in Securities by Employee Benefit Trust
1st Jun 20234:00 pmRNSDirector/PDMR Shareholding
1st Jun 20231:00 pmRNSDirector/PDMR Shareholding
30th May 20231:00 pmRNSDirector/PDMR Shareholding
25th May 20231:00 pmRNSDirector/PDMR Shareholding
22nd May 20231:00 pmRNSDirector/PDMR Shareholding
19th May 20231:00 pmRNSDirector/PDMR Shareholding
17th May 20232:00 pmRNSDirector/PDMR Shareholding
17th May 20237:00 amRNSFinal Results
28th Apr 202312:00 pmRNSDirector/PDMR Shareholding
18th Apr 20237:00 amRNS4th Quarter Update
27th Mar 20231:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20231:00 pmRNSDirector/PDMR Shareholding
20th Mar 20231:00 pmRNSDirector/PDMR Shareholding
20th Mar 20231:00 pmRNSDirector/PDMR Shareholding
14th Mar 20231:00 pmRNSDirector/PDMR Shareholding
14th Mar 20231:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.